People: Mesoblast Ltd (MSB.AX)
Mr. Michael R. Spooner, Bcom, ACA, MAICD, is Non-Executive Director of Mesoblast Ltd. He has been on the Company's Board since 2004. Michael Spooner is a well-known and respected business leader. He has an extensive network of relationships with investment firms and business communities across the globe, having spent the majority of the past 25 years living and working internationally. Mr Spooner consults for a number of listed and unlisted companies based in Australia and the United States. Most recently, he was a non-executive Director of Hawaii Biotech Inc., a specialty developer of vaccines from 2010 to 2011. In 2009, Mr Spooner was appointed Chairman of BiVACOR, a total artificial heart company. He was also a non-executive Director of Peplin Inc., a dermatology-focused skin cancer company from 2004 until the company was sold in 2009 for over $300 million. Previously, Mr Spooner was the Chairman of Mesoblast Limited from its initial listing in 2004 until 2007 and Managing Director & CEO of Ventracor Limited where he led the transformation of a small Australialisted life sciences company into the second highest performing stock on the S&P/ASX 200 Index. He was also a Principal Partner and Director of Consulting Services with PricewaterhouseCoopers (Coopers & Lybrand) in Hong Kong for several years. He was Non-executive director of Advanced Surgical Design (from 2010 to 2011). He is Chairman of the Audit & Risk Committee and Member of the Remuneration and Nomination Committee.
|Total Annual Compensation, AUD||Long-Term Incentive Plans, AUD||All Other, AUD||Fiscal Year Total, AUD|